Role of immunotherapy beyond advanced HCC

Episode 1 August 17, 2022 00:29:42
Role of immunotherapy beyond advanced HCC
COR2ED Medical Education
Role of immunotherapy beyond advanced HCC

Aug 17 2022 | 00:29:42

/

Show Notes

COR2ED Medical Education: In this podcast, liver cancer experts Prof. Amit Singal and Assoc. Prof Neil Mehta discuss recent advances in systemic and locoregional therapy for advanced and early stage hepatocellular carcinoma (HCC).  They focus on the role of immunotherapy and review data from three major congresses in 2022 (ASCO, WCGIC and ILC) together with recent publications. 

Prof. Amit Singal is Director of Liver Cancer Program at UT Southwestern Medical Center, Dallas, TX, USA and Assoc. Prof. Neil Mehta is Director of Liver Cancer Program at University of California San Francisco, USA.

Other Episodes

Episode 1

September 08, 2021 00:12:56
Episode Cover

Nurse management of AEs in patients receiving VEGFR-TKIs

In this podcast, Veerle Lamotte, an oncology nurse practitioner at Antwerp University Hospital and Paola Belardi, nurse chief at San Donato Hospital in Arezzo,...

Listen

Episode 2

February 08, 2023 00:28:03
Episode Cover

The nurses’ perspective: Systemic therapy in endometrial carcinoma

Medical education: Join Lead Nurse Andreia Fernandes and Clinical Nurse Specialist Jo Pearson as they explain how to help patients navigate the side effects...

Listen

Episode 1

October 13, 2021 00:20:43
Episode Cover

Choosing the Best Treatment Regimen in Multiple Myeloma: Episode 1 - the Newly Diagnosed Setting

In this medical education podcast series, myeloma experts Dr. Joshua Richter (Assistant Professor of Medicine and Director of Myeloma at the Tisch Cancer Institute...

Listen